Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111 Pharmaceutical Investing
Landmark Study Shows GeneSight Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder Genetics Investing
Novavax Reaches Significant Enrollment Milestone in the Prepare Phase 3 Trial of its RSV F Vaccine Biotech Investing
Aclaris Therapeutics Announces Availability of ESKATA (Hydrogen Peroxide) Topical Solution, 40% (w/w) Pharmaceutical Investing
Isodiol International Inc. Increases Size of Non-Brokered Offering and Retains Clarus Securities as Financial Advisor Biotech Investing
Big News Roundup: Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease; Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis Biotech Investing
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis Biotech Investing
